You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paclitaxel poliglumex

Showing 1 - 25 of 3,042
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell Trial in Syracuse (drug, biological, radiation)

Completed
  • Carcinoma, Squamous Cell
  • paclitaxel poliglumex
  • +2 more
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 29, 2021

Esophageal Cancer Trial in Providence (PPX with cisplatin and radiation)

Completed
Has Results
  • Esophageal Cancer
  • PPX with cisplatin and radiation
  • Providence, Rhode Island
    Lifespan Hospitals
Feb 13, 2020

Lung Cancer Trial in United States (carboplatin, paclitaxel, paclitaxel poliglumex)

Terminated
  • Lung Cancer
  • Scottsdale, Arizona
  • +40 more
Oct 2, 2020

Lung Cancer Trial in United States (gemcitabine HCl, paclitaxel poliglumex, vinorelbine tartrate)

Terminated
  • Lung Cancer
  • gemcitabine hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
Oct 2, 2020

Lung Cancer Trial in Canada, United States (carboplatin, paclitaxel, paclitaxel poliglumex)

Terminated
  • Lung Cancer
  • Birmingham, Alabama
  • +34 more
Oct 2, 2020

NSCLC Trial in United States (CT-2103/carboplatin, paclitaxel/carboplatin)

Withdrawn
  • NSCLC
  • Scottsdale, Arizona
  • +43 more
Oct 14, 2020

Lung Cancer Trial in United States (docetaxel, paclitaxel poliglumex)

Terminated
  • Lung Cancer
  • Hoover, Alabama
  • +34 more
Oct 2, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Active, not recruiting
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Clinical Observation
  • +4 more
  • Birmingham, Alabama
  • +314 more
Sep 28, 2021

NSCLC Trial in Worldwide (paclitaxel, paclitaxel poliglumex)

Terminated
  • NSCLC
  • Casa Grande, Arizona
  • +142 more
Nov 23, 2020

Peripheral Neuropathy Trial (Roflumilast, Placebo)

Not yet recruiting
  • Peripheral Neuropathy
  • (no location specified)
May 22, 2023

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin

Recruiting
  • Gastric Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin

Recruiting
  • Gastric Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

Recruiting
  • Adenocarcinoma of Stomach
  • Gentuximab Injection
  • Gentuximab Injection Placebo
  • Shanghai, Shanghai, China
    Shanghai Dongfang Hospital
Jun 16, 2023

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

Terminated
  • Soft Tissue Sarcoma
  • Basel, Switzerland
  • +7 more
Sep 27, 2022

Breast Cancer Trial (OnLife®, Placebo)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 12, 2023

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Gynecologic Cancer, Neuropathy;Peripheral Trial in Augusta (SensoniQ Treatment Station)

Not yet recruiting
  • Gynecologic Cancer
  • Neuropathy;Peripheral
  • SensoniQ Treatment Station
  • Augusta, Georgia
    James T Sonnenberg
Jul 31, 2023

Advanced Solid Tumor Trial (CVL218)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 9, 2023

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Chemo-induced Peripheral Neuropathy Trial (Curcumin, Paclitaxel)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • (no location specified)
Jul 21, 2023

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023